2013 No. 77
The Misuse of Drugs (Designation) (Amendment) Order (Northern Ireland) 2013
Made
Coming into operation
The Department of Health, Social Services and Public Safety makes the following Order in exercise of the powers conferred by section 7(4) of the Misuse of Drugs Act 19711 as adapted by section 7(9) of that Act and now vested in it2 and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 7(7) of that Act.
Citation, commencement and interpretation1
1
This Order may be cited as the Misuse of Drugs (Designation) (Amendment) Order (Northern Ireland) 2013 and shall come into operation on 10th April 2013.
2
The Interpretation Act (Northern Ireland) 19543 shall apply to this Order as it applies to an Act of the Assembly.
Amendment to the Misuse of Drugs (Designation) Order (Northern Ireland) 2001
2
The Misuse of Drugs (Designation) Order (Northern Ireland) 20014 is amended as provided by Articles 3 and 4.
3
In paragraph 1(a) of Part I of the Schedule (which specifies controlled drugs to which section 7(4) of the Misuse of Drugs Act 1971 applies) after “Cannabis” insert “(not being the substance specified in paragraph 4 of Part II of this Schedule)”.
4
After paragraph 3 of Part II of the Schedule (which specifies controlled drugs excepted from Part I)5 insert—
4
A liquid formulation—
a
containing a botanical extract of cannabis—
i
with a concentration of not more than 30 milligrams of cannabidiol per millilitre, and not more than 30 milligrams of delta-9-tetrahydrocannabinol per millilitre, and
ii
where the ratio of cannabidiol to delta-9-tetrahydrocannabinol is between 0.7 and 1.3,
b
which is dispensed through a metered dose pump as a mucosal mouth spray, and
c
which was approved for marketing by the Medicines and Healthcare products Regulatory Agency on 16th June 20106
Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 21st March 2013
(This note is not part of the Order)